COMBINING PATIENT PREFERENCES AND COMPARATIVE EFFECTIVENESS RESEARCH TO INFORM TREATMENT APPROACHES FOR MAINTENANCE THERAPY IN CROHN'S DISEASE

被引:0
|
作者
Hazlewood, Glen
Hull, Pauline
Hamidi, Nima
Panaccione, Remo
Seow, Cynthia H.
Novak, Kerri L.
Marshall, Deborah
Tomlinson, George
Kaplan, Gilaad
机构
关键词
D O I
10.1016/S0016-5085(17)32122-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1906
引用
收藏
页码:S591 / S592
页数:2
相关论文
共 50 条
  • [41] Loss of treatment response to infliximab maintenance therapy in Crohn's disease: A payor perspective
    Wu, Eric Qiong
    Mulani, Parvez M.
    Yu, Andrew Peng
    Tang, Jackson
    Pollack, Paul F.
    VALUE IN HEALTH, 2008, 11 (05) : 820 - 829
  • [42] Saccharomyces boulardii in Maintenance Treatment of Crohn’s Disease
    Mario Guslandi
    Gianni Mezzi
    Massimo Sorghi
    Pier Alberto Testoni
    Digestive Diseases and Sciences, 2000, 45 : 1462 - 1464
  • [43] The role of budesonide in Crohn's disease - Maintenance treatment
    Lofberg, R
    CROHN'S DISEASE - PATHOGENESIS AND MEDICAL THERAPY, 1996, 18 (01): : 77 - 79
  • [44] Review article: maintenance treatment of Crohn's disease
    Biancone, L
    Tosti, C
    Fina, D
    Fantini, M
    De Nigris, F
    Geremia, A
    Pallone, F
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 : 31 - 37
  • [45] Saccharomyces boulardii in maintenance treatment of Crohn's disease
    Guslandi, M
    Mezzi, G
    Sorghi, M
    Testoni, PA
    DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (07) : 1462 - 1464
  • [46] What Is the Optimal Maintenance Treatment for Crohn's Disease?
    Seibold, Frank
    INFLAMMATORY BOWEL DISEASES, 2008, 14 : S255 - S256
  • [47] Maintenance therapy versus episodic therapy with infliximab for Crohn's disease
    Subrata Ghosh
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 : 80 - 81
  • [48] Maintenance therapy versus episodic therapy with infliximab for Crohn's disease
    Ghosh, Subrata
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (02): : 80 - 81
  • [49] Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: a randomized-controlled trial
    Takagi, S.
    Utsunomiya, K.
    Kuriyama, S.
    Yokoyama, H.
    Takahashi, S.
    Iwabuchi, M.
    Takahashi, H.
    Takahashi, S.
    Kinouchi, Y.
    Hiwatashi, N.
    Funayama, Y.
    Sasaki, I.
    Tsuji, I.
    Shimosegawa, T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (09) : 1333 - 1340
  • [50] Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease
    Bohm, Matthew
    Xu, Ronghui
    Zhang, Yiran
    Varma, Sashidhar
    Fischer, Monika
    Kochhar, Gursimran
    Boland, Brigid
    Singh, Siddharth
    Hirten, Robert
    Ungaro, Ryan
    Shmidt, Eugenia
    Lasch, Karen
    Jairaith, Vipul
    Hudesman, David
    Chang, Shannon
    Lukin, Dana
    Swaminath, Arun
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Kane, Sunanda
    Loftus, Edward V., Jr.
    Shen, Bo
    Siegel, Corey A.
    Sandborn, William J.
    Dulai, Parambir S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (04) : 669 - 681